PlainPharmaWatch

CMS Open Payments · Tool

Central Indiana URS Consumables, LLC vs Epimed International, Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Epimed International, Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 9,897, versus 714 for the other company. Its single largest recorded recipient represents 1.0% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Central Indiana URS Consumables, LLC
HHI 714 · top recipient 0.1%
Ranked #1,165 of 1,838 companies by HHI
Epimed International, Inc
HHI 9,897 · top recipient 1.0%
Ranked #140 of 1,838 companies by HHI

Payment Overview

Total Payments
$507.6K
% of Industry
0.0%
Transactions
28
Avg per Transaction
$18.1K
Recipients
14
Avg per Recipient
$36.3K
Payment Types
1
Top Payment Type
Long-Term Medical Supply or Device Loan
Total Payments
$506.9K
% of Industry
0.0%
Transactions
33
Avg per Transaction
$15.4K
Recipients
33
Avg per Recipient
$15.4K
Payment Types
3
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Central Indiana URS Consumables, LLC vs Epimed International, Inc - total reported payments in CMS Open Payments PY2024

Central Indiana URS Consuma…$507.6KEpimed International, Inc$506.9K

Payment Types Breakdown

Central Indiana URS Consumables, LLC

Long-Term Medical Supply or Device Loan $214.2K

42.2%

Epimed International, Inc

Royalty or License $419.5K

82.8%

Consulting Fee $86.5K

17.1%

Food and Beverage $842.46

0.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Central Indiana URS Consumables, LLC

  1. 1

    JAMES HARRISON RAYBOURN

    $15,300.00 · 1 txns

  2. 2

    DAVID A GILLEY

    $15,300.00 · 1 txns

  3. 3

    BRADLEY G. ORRIS

    $15,300.00 · 1 txns

  4. 4

    ALEXANDER J TATEM

    $15,300.00 · 1 txns

  5. 5

    CHARLES W SCHWAB

    $15,300.00 · 1 txns

Epimed International, Inc

  1. 1

    Gabor Racz

    $504,252.53 · 16 txns

  2. 2

    John Nelson

    $975.27 · 1 txns

  3. 3

    Stanley Golovac

    $790.93 · 4 txns

  4. 4

    Eric Freeman

    $325.19 · 1 txns

  5. 5

    Sam Nia

    $271.76 · 1 txns

Summary Comparison

Metric Central Indiana URS Consumables, LLC Epimed International, Inc
Total Payments $507.6K $506.9K
% of Industry Total 0.0% 0.0%
Transaction Count 28 33
Avg per Transaction $18.1K $15.4K
Recipient Count 14 33
Avg per Recipient $36.3K $15.4K
Payment Type Count 1 3
Top Payment Type Long-Term Medical Supply or Device Loan Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.